Eziflex(Montmorency Tart Cherry)
Therapeutic Group: Herbal and Nutraceuticals
Presentation
Eziflex Capsule: Each Capsule contains Montmorency Tart Cherry 500 mg.
Description
Eziflex (Montmorency Tart Cherry) contains Cyanidin 3-(2G-glucosylrutinoside) and
Cyanidin 3 rutinoside. It inhibits formation of Monosodium Crystal in the joints by
inhibiting Xanthine Oxidase. It also reduces the extraction of urate from the Kidney
and lowers uric acid level. It suppresses Cox enzymes and inflammatory markers.
Montmorency Tart Cherry also acts as Antioxidant as it has the ability to scavenge
free radicals. It contains Melatonin that helps to maintain normal sleep cycle. It helps
to maintain a healthy cholesterol level as well.
Indications
Eziflex is indicated for Gout, Arthritis, Chronic Hyperurecemia, Exercise induced pain,
Muscle soreness, Joint inflammation and pain.
Dosage & Administration
1 capsule once or twice daily up to 12 weeks
Side Effects
In the recommended dose side-effects are rare. But sometimes patient may suffer GI
discomfort.
Precautions
Caution is needed if you are trying to conceive.
Use in Pregnancy & Lactation
Not recommended during pregnancy and lactation.
Drug Interaction
Concomitant use with monoamine oxidase inhibitors may alter the efficacy of Montmorency Tart Cherry.
Over Dose
Symptoms of overdose may include diarrhea and abdominal discomfort.
Storage
Do not store above 30 degree C. Protect from moisture and keep away from light and out
of the reach of children.
Commercial Pack
Eziflex Capsule: Each box contains 3 Alu-Alu blister strips of 10 capsules.